
PBMs make the argument for DIR fees after a litany of complaints from industry stakeholders.

PBMs make the argument for DIR fees after a litany of complaints from industry stakeholders.

The Trump Administration issued two rules rolling back the federal requirement that employers include birth control coverage in their group health plans. Here’s what you need to know.

Two opioid use disorder drugs have been recommended for approval by FDA committees.

Albert A. Rizzo, MD, senior medical advisor for the American Lung Association, says the increasing number of drugs in the pipeline could improve airflow and address the underlying disease process.

Widespread adoption of population-focused nursing practice will likely take place over the next five to 10 years. Here’s how to stay ahead of the curve.

New public opinion survey about opioid use from Prime Therapeutics has surprising results.

Moffitt Cancer Center expert shares her thinking on managing chemotherapy-related side effects.

Patients who lack resources likely won’t have improved health outcomes even with interventions. Some plans are exploring how to address the problem.

Education is a significant element of comprehensive care for COPD patients. In this Q&A, one expert shares her recommendations.

The CVS Health-Aetna potential merger will have healthcare executives rethinking traditional industry competitors. Here’s why.

Healthcare executives identify how the industry could be affected if the Aetna-CVS merger goes through.

As managed care leaders, better care for patients can be achieved through increased medical data exchange through diverse and collaborative organization involvement.

Is interoperability in healthcare a dream, or will payers, providers, and technology vendors finally come together to make data more available to one another?

High customer satisfaction has been linked with stronger loyalty, sales, and profits. So why hasn’t the healthcare industry caught on?

Finding technology solutions to diagnose and manage chronic conditions is critical to the future of healthcare.

Is your organization on pace with the biggest healthcare technology trends? Here’s your chance to find out.

Five healthcare tech trends that will make chronic care management a part of patients’ daily lives.

Analysis from RAND helps frame the potential of biosimilars to reduce spending on biologics.

New data from CMS show that ACOs succeed at producing quality gains and cost savings, but at least one effort begs to differ.

Find out what worked for this value-based physician and hospital network and Accountable Care Organization in Massachusetts.

How can we as an industry help address the growing need and demand for quality mental health services? One of the more promising solutions is the expanded use of certified physician assistants.

Key takeaways for healthcare executives from Bruno Medeiros, MD, associate professor of medicine (hematology) at the Stanford University Medical Center and director of Cancer Center Infusion Area Treatment Services at Stanford Cancer Center.

An Epstein Becker Green survey has surprising results about the expansion of telehealth services physicians and other behavioral health professionals can provide.

One study seeks to understand the underlying causes of racial and ethnic disparities in cancer survival. The results may be surprising.

The success of any value-based care model depends on achieving a strong relationship with members. Here’s three ways how.

While many analyses of Section 1a of the executive order cite doom and gloom for health plans, four tenuous contingencies all must take place in order for this to occur.

FDA approved a new once-weekly, single-dose autoinjector device to improve glycemic control in adults with type 2 diabetes.

Payers’ biggest concerns for 2018, health insurance exchange participation plans, and how offerings could change.

A new study has unbelievable findings about treating Medicare patients with diabetes.

A Robert Wood Johnson Foundation expert analyzes the Altarum Institute’s study on healthcare growth findings.